Entrepreneurship • Biotech
Dr. Kausar Samli is Associate Founder and CEO of Lectenz®Bio. Lectenz®Bio targets glycan biomarkers of clinical significance for investigation and to leverage them for advancing human health.
Living in Asia, the Middle East, Europe and North America shaped Dr. Samli’s global perspective. As a thought-leader, internationalist, scientist, and entrepreneur he advises teams on strategy, technology commercialization, leadership, and organizational development. He focuses on fostering innovation to enact positive rapid change critical for addressing regional and global challenges. Dr. Samli serves as a Horizon 2020 Expert for the European Commission, is an advisor to 1QBit Information Technologies, and previously served as a Singularity University Ambassador. He is a member of the Board of Directors of [email protected], the Board of Advisors of the Aubrey Daniels Institute, and Gerogia Bio’s Commercialization Committee. In recognition of his scholarship, leadership, and service he was elected as a member of the Blue Key Honor Society at the University of Georgia, and named Emerging Leader of the Year by Georgia Bio.
Dr. Samli has a unique blend of scientific expertise in cell-specific targeting, high-throughput screening, molecular evolution, protein engineering, and computational chemistry. He is a co-inventor on pending patents, the recipient of a Marie Curie Fellowship, has published biotech research, and presented at international conferences. He holds a Ph.D. in biochemistry, molecular biology, and computational chemistry from the University of Georgia, a M.S. in chemistry from Arizona State University, and a B.S. in biochemistry from the University of Texas at Austin. He attended Singularity University’s Global Solutions Program specializing in technology entrepreneurship and global grand challenges and has co-founded multiple start-ups.
Advances in biotech R&D and the promising applications being developed continue to push the boundaries of exploring, advancing, and transforming life. Increasingly, developments in advanced biomaterials, bioengineering, biophysics, neurobiology, and others are being enabled by the integration of technologies from computational sciences, engineering, physics, and machine learning. This session will explore recent advances in biotech, emerging technologies and their future applications, and challenges that lay ahead as we imagine and build a better world.